UK consults on allowing schools to stock spare adrenaline nasal sprays
The MHRA opened a UK-wide consultation on October 19 about allowing schools to keep spare adrenaline nasal sprays for allergic emergencies.
What the record says
The consultation, conducted jointly with Northern Ireland’s Department of Health, closes December 14, 2026. Schools can already hold spare adrenaline auto-injectors. The proposal would let them choose sprays, auto-injectors or both, with emergency supplies restricted to children known to be at risk of anaphylaxis and administration by appropriately trained staff. It would not require a particular product or replace pupils’ own prescribed medicine.
Source details and supporting locations.
Practical next step
Families, schools and healthcare professionals can read and respond to the consultation.
Limits and what is not established
This is a consultation about proposed medicines rules, not an enacted change or individual treatment advice. Separate allergy-safety requirements mentioned in the release apply to England.
Sources checked October 19, 2026. Later notices may change instructions or arrangements.
Original sources
Medicines and Healthcare products Regulatory Agency: original information